SCHEMBL5011669

SCHEMBL5011669

Cc1nc(N)c2cnn(-c3ccccc3)c2n1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.59
ALDH1A1 P00352 4/20 0.59
HSD17B10 Q99714 3/20 0.59
MEN1 O00255 3/20 0.59
KMT2A Q03164 3/20 0.59
EGFR P00533 1/20 0.59
CYP1A2 P05177 1/20 0.59
TSHR P16473 1/20 0.59
CYP2C19 P33261 1/20 0.59
PI4KA P42356 1/20 0.59
PI4K2B Q8TCG2 1/20 0.59
PI4K2A Q9BTU6 1/20 0.59
PI4KB Q9UBF8 1/20 0.59
HPGD P15428 1/20 0.58
MAPT P10636 3/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
HTT P42858 1/20 0.55
RAB9A P51151 2/20 0.52
LMNA P02545 1/20 0.52
NPC1 O15118 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5007676 0.86 XDH (0.48) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL14037083 0.85 NPC1 (0.67) KDM4EALDH1A1HSD17B10KMT2ATSHR
SCHEMBL5009708 0.85 GRM1 (0.51) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL5007641 0.85 TSHR (0.52) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL30297992 0.84 KDM4E (0.62) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL6287500 0.83 KDM4E (0.59) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL5007643 0.81 XDH (0.64) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL23274461 0.81 ALDH1A1 (0.59) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL6281507 0.81 KDM4E (0.58) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL5009824 0.81 NPC1 (0.63) KDM4EALDH1A1HSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080292561-A1 Pyrazolo-Pyrimidine Derivatives as Anti-Inflammatory Agents GLAXO GROUP LIMITED 2008-11-27 US disclosed
US-20080292561-A1 Pyrazolo-Pyrimidine Derivatives as Anti-Inflammatory Agents GLAXO GROUP LIMITED 2008-11-27 US disclosed
US-20080292561-A1 Pyrazolo-Pyrimidine Derivatives as Anti-Inflammatory Agents GLAXO GROUP LIMITED 2008-11-27 US disclosed
WO-2007054294-A1 PYRAZOLO-PYRIMIDINE DERIVATIVES AS ANTI-INFLAMMATORY AGENTS GLAXO GROUP LIMITED (GB) 2007-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080292561-A1 Pyrazolo-Pyrimidine Derivatives as Anti-Inflammatory Agents NOD1, FPR3, FPR1 KDM4E 1193/4885ALDH1A1 1359/4885HSD17B10 3125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.